Archives: 2022-04-20

PIER MARIA FORNASARI
2022-04-20

Combination Respiratory Vaccine Containing Recombinant SARS-CoV-2 Spike and Quadrivalent Seasonal Influenza Hemagglutinin Nanoparticles results effective in animals trials

On Wednesday, Maryland-based vaccine manufacturer Novavax released preliminary results from an early clinical phase study of its combination Covid/flu vaccine. The results found that the combination vaccine produced immune responses in patients that were comparable to those of its standalone flu and Covid vaccines. The company also found the vaccine formulation to be safe, with

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-20

Covid-19: Antidepressant Fluvoxamine Found to Be Effective as a therapy by Mc Gill University researchers

Researchers say the drug fluvoxamine is effective as an outpatient treatment for COVID-19. Experts say fluvoxamine could widen access to COVID-19 treatments, although they expect it to be a somewhat minor tool in the medical community’s toolkit. They also note that more studies need to be done on fluvoxamine’s effectiveness against the Omicron variant. Fluvoxamine,

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-20

Regenerative Potential of Solid Bone Marrow Aspirate Concentrate Compared to Platelet-Rich Fibrin

A new study compares the regenerative potential of blood/bone marrow aspirate concentrates obtained from arterial blood, venous blood, and bone marrow aspirate. The study, conducted in rabbits, is reported in the peer-reviewed journal Tissue Engineering Part A. Blood concentrate material such as platelet-rick fibrin (PRF) is used in clinical practice to promote tissue regeneration in the

Read More

No Comments InREGENERATIVE MEDICINE
PIER MARIA FORNASARI
2022-04-20

Three in ten survivors with COVID-19 developed a subset of symptoms associated with “Long Covid”: study of UCLA shows

New UCLA research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly known as “Long COVID.” People with a history of hospitalization, diabetes, and higher body mass index were most likely to develop the condition, while those covered by Medicaid, as opposed to commercial health insurance, or

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-20

What impacts has Covid-19 had on children: CDC study shows 87% Of Kids Hospitalized During Omicron Wave Were Unvaccinated.

About 87% of children hospitalized with Covid-19 when the omicron variant was dominant were unvaccinated, according to a study released Tuesday by the Centers for Disease Control and Prevention, offering a stark reminder of the risks of leaving children unvaccinated. KEY FACTS From mid-December to late February, unvaccinated children ages 5 to 11 had a hospitalization rate

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-20

3% of adults with COVID pneumonia develop new-onset dementia

Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study published in Open Forum Infectious Diseases. University of Missouri at Columbia researchers conducted a case series of COVID-19 pneumonia patients along

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-14

COVID-19 therapy: better in combination than alone. Research published by Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU).

How a well-known drug can become a game changer There is a steadily growing arsenal of drugs for COVID-19. Researchers from Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU) Berlin have studied the mechanisms of action of antiviral and anti-inflammatory drugs. Their findings, which have been published in Molecular Therapy, show

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-14

New York State Department of Health Announces Emergence of Recently Identified, Highly Contagious Omicron Subvariants in New York and Urges Continued Vigilance Against COVID-19

The New York State Department of Health today announced the emergence of two Omicron subvariants in New York State, BA.2.12 and BA.2.12.1. Both variants are sub-lineages of BA.2, which now accounts for 80.6% of COVID-19 infections in New York. The subvariants have been estimated to have a 23% – 27% growth advantage above the original BA.2 variant.

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-04-14

Cell-Derived Exosome Therapy May Help Repair Abnormal Heart Rhythm

Cedars-Sinai Investigators Found It Also Reduced Scarred Heart Tissue in Animals Vesicles secreted from human heart cells may repair damaged tissue and prevent lethal heart rhythm disorders, according to a new study from investigators in the Smidt Heart Institute at Cedars-Sinai. The research, published in the European Heart Journal, could lead to a new way to

Read More

No Comments InADVANCED THERAPY MEDICINAL PRODUCT
PIER MARIA FORNASARI
2022-04-14

Cell Treatment Slows Disease in Duchenne Muscular Dystrophy Patients

Cell Therapy Developed by Smidt Heart Institute Leader Delays Disease Progression in Patients Who Have Few Treatment Options A cell therapy developed by the executive director of the Smidt Heart Institute stabilizes weakened muscles–including the heart muscle–in Duchenne muscular dystrophy patients, a new study published in the international peer-reviewed journal The Lancet shows. If the HOPE-2 study’s

Read More

No Comments InADVANCED THERAPY MEDICINAL PRODUCT